If you experience serious side effects, such as allergic reactions, low blood sugar levels, or severe gastrointestinal issues, do not take the next dosage of semaglutide before consulting your healthcare provider
Patients should be educated about symptoms of both hypothyroidism (fatigue, cold intolerance, weight gain, constipation) and hyperthyroidism (anxiety, palpitations, heat intolerance, tremor) to facilitate early detection of thyroid dysfunction
Tirzepatide is a dual GIP and GLP-1 receptor agonist approved by the FDA under the brand names Mounjaro and Zepbound
However, once blood glucose reaches normal levels, continued administration of GLP-1 does not further stimulate insulin secretion, and blood glucose remains stable
352.204.0094 [gtranslate] Choosing the most effective metabolic solution feels confusing because the options Semaglutide and Tirzepatide seem so similar on the surface
Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes
